EYLEA sol inj 8 mg/0.07ml ser prê
7680623930033
CH-62393
S01LA05
11.99.0.
Reimbursement limitations:
EYLEA7
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) – DMLA, d’une …
1 / 2
google
Details
- Product number
- 6239302
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- afliberceptum 8 mg, arginini hydrochloridum, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.07 ml.
Articles (1)
Eylea 8 mg/0.07ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
8.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 936.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2025
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 62393
- Drug name
- Eylea, Injektionslösung zur Intravitrealen Anwendung in einer Fertigspritze
- Galenic form
- LSINJ
- ATC Code
- S01LA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/10/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EYLEA sol inj 8 mg/0.07ml ser prê
- Description (DE)
- EYLEA Inj Lös 8 mg/0.07ml Fertspr
- Market launch
- 04/02/2025
- Narcotic (BTM)
- No